OOIR: Observatory of International Research

Papers

(The H4-Index of Radiation Oncology is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Efficacy and safety of tyrosine kinase inhibitors with thoracic radiotherapy for patients with oncogene-mutated non-small cell lung cancer: a meta-analysis	76
Dosimetric comparison of two dose expansion methods in intensity modulated radiotherapy for breast cancer	69
125I seed brachytherapy for non-central pelvic recurrence of cervical cancer after external beam radiotherapy	68
A multifunctional targeted nano-delivery system with radiosensitization and immune activation in glioblastoma	62
Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study	59
Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer	50
Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prost	45
Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer	45
CT-based auto-segmentation of multiple target volumes for all-in-one radiotherapy in rectal cancer patients	42
Radiotherapy refusal in breast cancer with breast-conserving surgery	37
CircRNA_101491 regulated the radiation sensitivity of esophageal squamous cell carcinomas via sponging miR-125a-5p	34
A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy	33
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov	32
Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy	32
Pamiparib as consolidation treatment after concurrent chemoradiotherapy of limited-stage small cell lung cancer: a single-arm, open-label phase 2 trial	31
Outcome of patients with soft tissue sarcomas of the extremities and trunk treated by (neo)adjuvant intensity modulated radiation therapy with curative intent	31
Estimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia	31
Preoperative short-course radiotherapy followed by consolidation chemotherapy for treatment with locally advanced rectal cancer: a meta-analysis	30
The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma	30
Compliance of volunteers in a fully-enclosed patient rotation system for MR-guided radiation therapy: a prospective study	29
Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)	29
Comparison of deep learning networks for fully automated head and neck tumor delineation on multi-centric PET/CT images	27
Using meta-analysis and CNN-NLP to review and classify the medical literature for normal tissue complication probability in head and neck cancer	27
Knowledge-based DVH estimation and optimization for breast VMAT plans with and without avoidance sectors	27
Linear accelerator-based stereotactic radiotherapy for brain metastases, including multiple and large lesions, carries a low incidence of acute toxicities: a retrospective analysis	25